Document:

EX-10.1

 Exhibit 10.1 

ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN 

FORM OF OPTION AGREEMENT 
 This Option
Agreement certifies that, pursuant to the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”), the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted an option (the
“Option”) to purchase shares of the Company’s common stock, $.001 par value per share (the “Shares”), as follows: 
  

			
	 Name of Participant:
 Number of Option
Shares:
 Type of Stock Option Grant:
 Date of
Grant:
	 	
	 Exercise Price:
	 	$         per Share

 This Option is subject to all the terms, conditions and limitations set forth in the 2014 Plan, which is incorporated herein
by reference, and to the following additional terms specified by the Board of Directors of the Company. Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the 2014 Plan. The Option shall be exercisable as
follows: 
 [Vesting schedule to be inserted] 

Payment of the Exercise Price shall be made in accordance with Paragraph 7(d) of the 2014 Plan and shall include payment by means of a broker-assisted
“cashless exercise” as set forth in Paragraph 7(d)(ii)(B) and may include at the discretion of the Company, payment by “net exercise” as set forth in Paragraph 7(d)(ii)(c). 

The Option shall terminate ten years from the Date of Grant provided, however, that in the event of Termination of Service (as defined below) before exercise
of the Option the following rules shall apply: 
 (i) If the Participant’s Termination of Service is for Cause, no
portion of the Option may be exercised, and the Option will immediately expire upon the Termination of Service; 
 (ii) The
Option may be exercised after the Participant’s Termination of Service only to the extent that the Option was vested as of the Termination of Service; 

(iii) Unless the Participant’s Termination of Service is the result of the Participant’s death or Disability, the
Participant may exercise the vested portion of an Option within three months after such Termination of Service; 
 (iv) If
the Participant’s Termination of Service is the result of the Participant’s death or Disability, the Participant may exercise the vested portion of an Option within 12 months after Termination of Service; and 

(v) After the Participant’s death, his or her beneficiary may exercise the Option only to the extent that the deceased
Participant was entitled to exercise such Option as of the date of his or her death. 
 If the Committee determines, subsequent to a Participant’s
Termination of Service but before exercise of the Option, that either before or after the Participant’s Termination of Service the Participant engaged in conduct that constitutes “Cause,” then the Participant’s right to exercise
the Option is forfeited immediately. 

 Termination of Service means the date the Participant ceases to be an Eligible Person in any capacity. The Option
shall not be affected by the change of a Participant’s status with in or among the Company and any Affiliates, so long as the Participant remains an Eligible Person. Unless the Committee or a Company policy provides otherwise, a leave of
absence authorized by the Company or the Committee (including sick leave or military leave) from which return to service is not guaranteed by statute or contract shall be characterized as a Termination of Service if the Participant does not return
to service within three months; such Termination of Service shall be effective as of the first day that is more than three months after the beginning of the period of leave. If the ability to return to service upon the expiration of such leave is
guaranteed by statute or contract, but the Participant does not return, the leave shall be characterized as a Termination of Service as of a date established by the Committee or Company policy. If an entity ceases to be an Affiliate, Termination of
Service shall be deemed to have occurred with respect to the Participant in respect of such Affiliate who does not continue as an Eligible Person in respect of the Company or another Affiliate after such giving effect to such Affiliate’s change
in status. 
 The Option is not assignable or transferable, other than as provided in the 2014 Plan. In no event shall the Company be required to issue
fractional shares. In accordance with Paragraph 14(c) of the 2014 Plan, the Company may in its sole discretion withhold in kind from the Shares otherwise deliverable to the Participant on exercise of the Option the minimum statutory amount of
federal, state and local withholding taxes attributable to such amount that is considered compensation includable in the Participant’s gross income. 

This Option Agreement, together with the 2014 Plan and any other written agreement between the Company and the Participant relevant to the subject matter
hereof and executed contemporaneously herewith or hereafter, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings
relating to the subject matter hereof and no other statement, representation, warranty, covenant or agreement shall affect or be used to interpret, change or restrict, the express terms and provisions of this Stock Option Grant, provided, however,
in any event, this Option Agreement shall be subject to and governed by the 2014 Plan. 
 In witness whereof, the Company has caused this Option Agreement
to be executed by its duly authorized officers. 
  

							
	ARIAD PHARMACEUTICALS, INC.	 		 	PARTICIPANT
				
	By:	 	  
	 		 	  

		 	Edward M. Fitzgerald	 		 	
		 	Executive Vice President, Chief Financial Officer	 		 	

  
 2EX-10.2

 Exhibit 10.2 

ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN 

FORM OF RESTRICTED STOCK UNIT AGREEMENT 

This Restricted Stock Unit Agreement certifies that, pursuant to the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”),
the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted the right to receive shares of Common Stock, $.001 par value per share, of the Company (the “Grant”), payable as soon as administratively feasible
following each of the following vesting dates, assuming the Participant is then employed by the Company: 
  

			
	Name of Participant:	  	
	Number of Shares:	  	
	Grant Date:	  	
	Grant Price:	  	$.001 per Share
		
	Vesting Date	  	Shares to be Delivered
		
	[Vesting schedule to be inserted]	  	

 The Grant is subject to all the terms, conditions and limitations set forth in the 2014 Plan, which is incorporated herein by
reference, and to the following additional terms specified by the Board of Directors of the Company. Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the 2014 Plan. 

Grant Price. The Grant Price has been deemed to have been paid by services rendered to the Company by the Participant. 

Tax Considerations. This award is intended to qualify as a “short-term deferral” exempt from Section 409A of the Internal Revenue Code
of 1986, as amended. The Participant acknowledges and agrees that he/she is responsible for all federal, state and local taxes applicable to the Shares when issued and will by the date requested by the Company deposit with the Company an amount of
cash equal to the amount determined by the Company to be required with respect to the statutory minimum withholding tax due. 
 If the Participant does not
provide the Company with the required cash payment in a timely manner as set forth above, then the Company shall receive payment of the statutory minimum tax withholding as follows: 

(a) if the Company believes that a sale of shares can be made in compliance with applicable securities laws including, but not limited to,
through entering into a Rule 10b5-1 trading plan at a time when the Participant is not in possession of material nonpublic information, then the Company shall receive payment in cash through a brokerage sale by the Participant of a sufficient number
of Shares to cover the statutory minimum tax withholding obligation of the Company, after deduction of the broker’s commission, and which sale provides for remittance directly by the broker to the Company of the cash necessary in order for the
Company to satisfy its statutory minimum tax withholding obligation; or 

 (b) if the Participant cannot sell any Shares in accordance with (a) above, then the Company
shall reduce the number of Shares to be issued to the Participant in an amount equal to the statutory minimum withholding tax due and payable by the Company using the Fair Market Value as set forth in Section 2(o) of the 2014 Plan. Fractional
shares will not be retained to satisfy any portion of the withholding tax. Accordingly, the Participant agrees that in the event that the amount of withholding tax owed would result in a fraction of a share being owed, that amount will be satisfied
by withholding the fractional amount from the Participant’s bi-weekly pay. 
 In witness whereof, the Company has caused this Restricted Stock Unit
Agreement to be executed by its duly authorized officer. 
  

							
	ARIAD PHARMACEUTICALS, INC.	 		 	PARTICIPANT
				
	By:	 	  
	 		 	  

		 	Edward M. Fitzgerald	 		 	
		 	Executive Vice President, Chief Financial Officer	 		 	

  
 2EX-10.3

 Exhibit 10.3 

ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN 

FORM OF RESTRICTED STOCK AGREEMENT 
 This
Restricted Stock Agreement certifies that, pursuant to the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”), the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted shares of
Common Stock, $.001 par value per share, of the Company (the “Stock Grant”), as follows: 
  

			
	Name of Participant:	  	
	Number of Granted Shares:	  	
	Grant Price:	  	$.001 per Share
	Grant Date:	  	

 The Stock Grant is subject to all the terms, conditions and limitations set forth in the 2014 Plan, which is incorporated
herein by reference, and to the following additional terms specified by the Board of Directors of the Company. Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the 2014 Plan. 

Grant Price. The Grant Price has been deemed to have been paid by services rendered to the Company by the Participant. 

Lapsing Forfeiture Right. In the event that the Participant no longer is an employee, director or consultant of the Company or an Affiliate prior to
[insert date], the Participant (or the Participant’s beneficiary) shall forfeit all or any part of the Granted Shares which have not yet lapsed in accordance with the schedule set forth below (the “Lapsing Forfeiture Right. In
addition to the right of forfeiture set forth in Section 9(e) of the 2014 Plan, the Company’s Lapsing Forfeiture Right is as follows: 

[Lapsing Forfeiture Right to be inserted] 

Restrictions on Transfer. All Granted Shares which are subject to the Lapsing Forfeiture Right may not be sold, transferred, assigned, hypothecated,
pledged, encumbered or otherwise disposed of, whether voluntarily or by operation of law, other than to the Company. The Company shall not be required to transfer any Granted Shares on its books which shall have been sold, assigned or otherwise
transferred in violation of this Restricted Stock Agreement. 
 Dividends and Voting. The Participant shall be entitled, effective as of the Grant
Date, to exercise the rights of a shareholder of Common Stock of the Company, including the right to vote the Granted Shares and the right to receive dividends on the Granted Shares as set forth in Section 9(d)(i) of the 2014 Plan. 

Escrow of Granted Shares. Until the Lapsing Forfeiture Right shall lapse in full, the certificate(s) representing the Granted Shares shall be held in
escrow by the Company or its designee. In the event of the forfeiture by the Participant of Granted Shares subject to the Lapsing Forfeiture Right, the Company shall release from escrow and cancel the certificate(s) for the number of Granted Shares
so forfeited. 

 Legend. In addition to any legend required pursuant to the 2014 Plan or by law, including a legend
required by virtue of the fact that the Participant is an affiliate (as defined in Rule 144(a)(1) of the Securities Act of 1933, as amended) of the Company, all certificates representing the Granted Shares to be issued to the Participant pursuant to
this Restricted Stock Agreement shall contain the following legend: 
 “TRANSFER OF THIS CERTIFICATE AND THE SHARES REPRESENTED HEREBY
IS RESTRICTED PURSUANT TO THE TERMS OF THE ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN AND A RESTRICTED STOCK GRANT AGREEMENT BETWEEN ARIAD PHARMACEUTICALS, INC. AND PARTICIPANT. A COPY OF SUCH PLAN AND AGREEMENT IS ON FILE AT THE
PRINCIPAL EXECUTIVE OFFICES OF ARIAD PHARMACEUTICALS, INC.” 
 Tax Considerations. The Participant acknowledges and agrees that he/she is
responsible for all federal, state and local taxes applicable to the granted Shares. 
 If the Participant is an employee of the Company, he/she will by the
date requested by the Company deposit with the Company an amount of cash equal to the amount determined by the Company to be required with respect to the statutory minimum withholding tax due. If the Participant does not provide the Company with the
required cash payment in a timely manner as set forth above, then the Company shall receive payment of the statutory minimum tax withholding as follows: 

(a) if the Company believes that a sale of shares can be made in compliance with applicable securities laws including, but not limited to,
through entering into a Rule 10b5-1 trading plan at a time when the Participant is not in possession of material nonpublic information, then the Company shall receive payment in cash through a brokerage sale by the Participant of a sufficient number
of the vested Granted Shares to cover the statutory minimum tax withholding obligation of the Company, after deduction of the broker’s commission, and which sale provides for remittance directly by the broker to the Company of the cash
necessary in order for the Company to satisfy its statutory minimum tax withholding obligation; or 
 (b) if the Participant cannot sell any
Granted Shares in accordance with (a) above, then the Company shall reduce the number of vested Granted Shares to be released from escrow and delivered to the Participant in an amount equal to the statutory minimum withholding tax due and
payable by the Company using the Fair Market Value as set forth in Section 2(o) of the 2014 Plan. Fractional shares will not be retained to satisfy any portion of the withholding tax. Accordingly, the Participant agrees that in the event that
the amount of withholding tax owed would result in a fraction of a share being owed, that amount will be satisfied by withholding the fractional amount from the Participant’s bi-weekly pay. 

In witness whereof, the Company has caused this Restricted Stock Agreement to be executed by its duly authorized officer. 

 

							
	ARIAD PHARMACEUTICALS, INC.	 		 	PARTICIPANT
				
	By:	 	  
	 		 	  

		 	Edward M. Fitzgerald	 		 	
		 	Executive Vice President, Chief Financial Officer	 		 	

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]